Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bifidobacteria

ABSTRACT: Effects of dietary yogurt consumption on the gastrointestinal (GI) microbial communities of healthy human subjects

PROVIDER: PRJNA351747 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5015150.fastq.gz	Fastqsanger.gz
	SRR5015160.fastq.gz	Fastqsanger.gz
	SRR5015180.fastq.gz	Fastqsanger.gz
	SRR5015190.fastq.gz	Fastqsanger.gz
	SRR5015260.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 51

Similar Datasets

human gut metagenome

Project description:Effects of dietary yogurt consumption on the gastrointestinal (GI) microbial communities of healthy human subjects

| PRJNA353325 | ENA

Transcription profiling by array of human blood in dairly product consumption time series.

Project description:With the aim of investigating the genome-wide postprandial effects of single servings ingestion of milk and yogurt on gene expression in the blood cells of human subjects and to identify the downstream physiological processes regulated by the differentially expressed genes we conducted a randomized, controlled, single blinded, crossover study on 6 healthy male individuals. 540g of milk or yogurt was ingested after an overnight fasting. Blood samples were collected before (0h) and 2h, 4h, 6h after the ingestion and the blood cell transcriptome was analyzed using a linear kinetic analysis.

2010-10-01 | E-MEXP-2571 | biostudies-arrayexpress

Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice

Project description:Meta-analyses suggest that yogurt consumption reduces type 2 diabetes incidence in humans, but the molecular basis of these observations remains unknown. Here we show that dietary yogurt intake preserves whole-body glucose homeostasis and prevents hepatic insulin resistance and liver steatosis in a dietary mouse model of obesity-linked type 2 diabetes. Fecal microbiota transplantation studies reveal that these effects are partly linked to the gut microbiota. We further show that yogurt intake impacts the hepatic metabolome, notably maintaining the levels of branched chain hydroxy acids (BCHA) which correlate with improved metabolic parameters. These metabolites are generated upon milk fermentation and concentrated in yogurt. Remarkably, diet-induced obesity reduces plasma and tissue BCHA levels, and this is partly prevented by dietary yogurt intake. We further show that BCHA improve insulin action on glucose metabolism in liver and muscle cells, identifying BCHA as cell-autonomous metabolic regulators and potential mediators of yogurt's health effects.

2022-02-03 | MTBLS442 | MetaboLights

E-GEOD-18162

Project description:Effects of moderate ethanol consumption during pregnancy on placental gene expression

2015-09-07 | E-GEOD-18162 | ExpressionAtlas

E-GEOD-75011

Project description:RNA-seq of Th2 cells from subjects with allergic asthma, allergic rhinitis or healthy non-atopic subjects

2019-05-14 | E-GEOD-75011 | ExpressionAtlas

Project description:Equibiotic-GI Consumption

| PRJNA573092 | ENA

Comparison of gene expressions between LB81 yogurt-intake mice and control mice in the intestine, liver and spleen at 28 months of age

Project description:We performed the long-term administration experiment using a yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 (LB81 yogurt) for 20 months in order to understand the effects of the long-term intake of probiotics on mice. Microarrays were used to compare the gene expressions of the intestine, liver and spleen tissues between control mice and LB81 yogurt-intake mice at 28 months of age. Abbreviations used: A, LB81 yogurt-intake mice; C, control mice

2018-06-02 | GSE104375 | GEO

VSL#3 supplementation of mice is associated primarily with changes in ileal microbiota composition and amelioration of DSS-induced colitis.

Project description:Inflammatory bowel diseases encompass gastrointestinal illnesseses typified by chronic inflammation, loss of epithelial integrity and gastrointestinal microbiota dysbiosis. In an effort to counteract these characteristic perturbations, we used stem cells and/or a probiotic preparation in a murine model of Dextran Sodium Sulfate induced colitis to examine both their efficacy in ameliorating disease and impact on niche-specific microbial communities of the lower GI tract. Colitis was induced in C57BL/6 mice by administering 3% DSS in drinking water for 10 days prior to administering one of three treatment plans: daily probiotic (VSL#3) supplementation for 3 days, a single tail vein injection of 1x106 murine mesenchymal stem cells, or both. Controls included DSS-untreated mice and DSS-treated mice that received no therapy. Ileal, cecal and colonic sections were collected for microbiota and histological analyses. Microbiota profiling revealed distinct bacterial community compositions in the ileum, cecum and colon of control untreated animals, all of which were predicted in silico to be enriched for a number of discrete KEGG pathways, indicating compositional and functional niche specificity in healthy animals. DSS- treatment perturbed community composition in all three niches with ileal communities exhibiting the greatest change relative to control animals. Stem cell, VSL#3 and the combination treated animals exhibited treatment-specific microbiota composition in the lower GI tract, though disease scores were only improved in VSL#3 treated animals. This VSL#3-associated shift in the ileal microbiota was characterized by significant Enterobacteriaceae enrichment compared to colitic animals (p<0.05),

2014-09-01 | GSE56137 | GEO

E-GEOD-5388

Project description:Transcription profiling of human brain tissue from subjects with bipolar disorder and healthy controls

2025-01-24 | E-GEOD-5388 | ExpressionAtlas

E-GEOD-5390

Project description:Transcription profiling of human adult postmortem brain tissue from Down syndrome and healthy control subjects

2025-01-24 | E-GEOD-5390 | ExpressionAtlas